Scientific articles index

Found 12 results

Sort by: [ Author (Asc)] Title Type Year
Filters: Author is Raymond L. Benza, MD  [Clear All Filters]
B
Badesch DB, Barst RJ, Benza RL, et al. "REVEAL Registry: Baseline Characteristics of the First 1226 Enrolled Patients.". In: 2008 Scientific Sessions at PHA International PH Conference.; 2008.
Barst RJ, Ivy D, Badesch DB, et al. "REVEAL Registry: Baseline Characteristics of Patients with Childhood-Onset PAH.". In: 2008 Scientific Sessions at PHA International PH Conference.; 2008.
Barst RJ, McGoon M, Bourge R, et al. "Ambulatory right ventricular and pulmonary artery pressure response to treatment with bosentan and treprostinil in patients with pulmonary arterial hypertension .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
Barst RJ, Frantz RP, Bourge R, et al. "Relation Between Pulmonary Arterial Pressure Response and Exercise Tolerance in Pulmonary Arterial Hypertension Patients Treated with Bosentan or Treprostinil .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
Benza RL, Barst RJ, Bourge R, et al. "Hemodynamic response during six-minute walk tests and during daily living in patients with pulmonary arterial hypertension .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
Barst RJ, McGoon M, Bourge R, et al. "Ambulatory right ventricular and pulmonary artery pressure response to treatment with bosentan and treprostinil in patients with pulmonary arterial hypertension .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
Benza RL, Barst RJ, Bourge R, et al. "Hemodynamic response during six-minute walk tests and during daily living in patients with pulmonary arterial hypertension .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
Barst RJ, Frantz RP, Bourge R, et al. "Relation Between Pulmonary Arterial Pressure Response and Exercise Tolerance in Pulmonary Arterial Hypertension Patients Treated with Bosentan or Treprostinil .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
Benza RL, Krichman A, McLaughlin VV, et al. "One Year Experience with Intravenous Treprostinil in Pulmonary Arterial Hypertension (PAH) Patients.". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
Benza RL, Barst RJ, Bourge R, et al. "Hemodynamic response during six-minute walk tests and during daily living in patients with pulmonary arterial hypertension .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
Barst RJ, Frantz RP, Bourge R, et al. "Relation Between Pulmonary Arterial Pressure Response and Exercise Tolerance in Pulmonary Arterial Hypertension Patients Treated with Bosentan or Treprostinil .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
Benza RL, Barst RJ, Bourge R, et al. "Hemodynamic response during six-minute walk tests and during daily living in patients with pulmonary arterial hypertension .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
Barst RJ, McGoon M, Bourge R, et al. "Ambulatory right ventricular and pulmonary artery pressure response to treatment with bosentan and treprostinil in patients with pulmonary arterial hypertension .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
M
McGoon M, Farber H, Krichman A, et al. "Registry to EValuate Early And Long-term PAH Disease Management (REVEAL Registry™) .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
McGoon M, Farber H, Krichman A, et al. "Registry to EValuate Early And Long-term PAH Disease Management (REVEAL Registry™) .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
McGoon M, Farber H, Krichman A, et al. "Registry to EValuate Early And Long-term PAH Disease Management (REVEAL Registry™) .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
McGoon M, Farber H, Krichman A, et al. "Registry to EValuate Early And Long-term PAH Disease Management (REVEAL Registry™) .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
B
Barst RJ, Frantz RP, Bourge R, et al. "Relation Between Pulmonary Arterial Pressure Response and Exercise Tolerance in Pulmonary Arterial Hypertension Patients Treated with Bosentan or Treprostinil .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
M
McGoon M, Farber H, Krichman A, et al. "Registry to EValuate Early And Long-term PAH Disease Management (REVEAL Registry™) .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
G
Galie N, Benza RL, Rubin LJ, et al. "Bosentan improves hemodynamics and delays time to clinical worsening in patients with mildly symptomatic pulmonary arterial hypertension: Results of the EARLY study.". In: 2008 Scientific Sessions at PHA International PH Conference.; 2008.
B
Barst RJ, McGoon M, Bourge R, et al. "Ambulatory right ventricular and pulmonary artery pressure response to treatment with bosentan and treprostinil in patients with pulmonary arterial hypertension .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
Benza RL, Barst RJ, Bourge R, et al. "Hemodynamic response during six-minute walk tests and during daily living in patients with pulmonary arterial hypertension .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
Barst RJ, Frantz RP, Bourge R, et al. "Relation Between Pulmonary Arterial Pressure Response and Exercise Tolerance in Pulmonary Arterial Hypertension Patients Treated with Bosentan or Treprostinil .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
M
McGoon M, Farber H, Krichman A, et al. "Registry to EValuate Early And Long-term PAH Disease Management (REVEAL Registry™) .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
McGoon M, Farber H, Krichman A, et al. "Registry to EValuate Early And Long-term PAH Disease Management (REVEAL Registry™) .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.